WH
Wedbush Healthcare Partners
Los Angeles, California, United StatesFounded 2020
Wedbush Healthcare Partners is a venture capital fund affiliated with Wedbush Financial Services, focused on investing in healthcare and biotechnology companies. The firm participates in venture financing rounds from Series A through late-stage, having invested in companies such as Odyssey Therapeutics and Crystalys Therapeutics.
86% of their portfolio is in Biotech & Life Sciences. They made 3 investments in the last 12 months. Their most common stage is series-b (43% of deals). Average disclosed round size is $160.7M (across 7 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series B
Last 12 Mo
3
Team
AJ
Alex Joslyn
Co-Founder & Partner
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Crystalys Therapeutics Inc | Series B | $130M | Jul 2026 |
| AAvere Therapeutics | Unknown | $320M | Jan 2026 |
 Crystalys | Series A | $205M | Sep 2025 |
| Crystalys Therapeutics Inc | Series A | $205M | Sep 2025 |
 BioTheryX | Series E | $92M | May 2021 |
 Shoreline Biosciences | Series B | $43M | Apr 2021 |
| Crystalys | Series B | $130M | — |
Top Co-Investors
Pontifax4 shared
Longwood Fund4 shared
Alexandria Venture Investments4 shared
SR One4 shared
Lightstone Ventures4 shared
Catalys Pacific4 shared
Novo Holdings A/S3 shared
Cormorant Asset Management3 shared
Wellington Management3 shared
Logos Capital2 shared
funds managed by abrdn Inc.2 shared
Pivotal Life Sciences2 shared
Frazier Life Sciences2 shared
Soleus Capital2 shared
HBM Healthcare Investments2 shared
KB Partners1 shared
Bowery Capital1 shared
Struck Capital1 shared
Kite, a Gilead Company1 shared
Last updated: 20 October 2026